Drug Shortage Report for INCRUSE ELLIPTA

Last updated on 2020-02-06 History
Report ID 101563
Drug Identification Number 02423596
Brand name INCRUSE ELLIPTA
Common or Proper name umeclidinium (as bromide) dry powder for oral inhalation
Company Name GLAXOSMITHKLINE INC
Active Ingredient(s) UMECLIDINIUM
Strength(s) 62.5MCG
Dosage form(s) POWDER
Route of administration INHALATION
Packaging size 7's
ATC code R03BB
ATC description
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2019-12-10
Estimated end date 2020-02-15
Actual end date 2020-02-05
Shortage status Resolved
Updated date 2020-02-06
Company comments
Health Canada comments
Company contact information 1-800-387-7374

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2020-02-06 English Compare
v4 2020-02-05 French Compare
v3 2020-02-05 English Compare
v2 2019-12-18 French Compare
v1 2019-12-18 English Compare